News | March 17, 2023
Jubilant receives additional CAD 23.8 million loan facility for CMO Montreal facility
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Cleocin Hydrochloride Capsules market achieved annual sales of approximately US $33.6 million
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
The facility has been set up to manufacture tuberculosis testing cartridges
ALPLA is expanding its presence in the global market for pharmaceutical packaging by establishing a joint venture with Inden Pharma
The company will be submitting the responses to US FDA observations within stipulated timeline
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
The Development Center with its state-of-the art laboratories and flexible pilot capacities is set to become Siegfried's global research and development hub for its Drug Products sites, strengthening the global network
Subscribe To Our Newsletter & Stay Updated
